Results 141 to 150 of about 5,796 (217)

The impact of nirsevimab prophylaxis on RSV hospitalizations: a real-world cost-benefit analysis in Tuscany, Italy. [PDF]

Front Public Health
Lastrucci V, Pacifici M, Alderotti G, Puglia M, Berti E, Barbati F, Lodi L, Boscia S, Nieddu F, Indolfi G, Peroni D, Martini M, Azzari C, Voller F, Moriondo M, Ricci S.   +15 more
europepmc   +1 more source

Palivizumab Effectiveness in Preventing Respiratory Syncytial Virus-Associated Hospitalization in High-Risk Infants and Children

, 2015
Evan J. Anderson, Phyllis Carosone, Ram Yogev, Jumi Yi, Eric A. F. Simões   +4 more
openalex   +1 more source

Nirsevimab for preventing respiratory syncytial virus lower respiratory tract infections in infants: a systematic review and meta-analysis. [PDF]

Front Public Health
Soudani S, Bertizzolo L, Ghemmouri M, Chappell M, McCool R, Reddish K, Miller P, Barker E, Fewster H.   +8 more
europepmc   +1 more source

Cost-Effectiveness and Public Health Impact of Universal Prophylaxis with Nirsevimab Against Respiratory Syncytial Virus (RSV) Infections in all Infants in Japan. [PDF]

Infect Dis Ther
Noto S, Kieffer A, Soudani S, Arashiro T, Tadera C, Eymere S, Lemański T, Wang X.   +7 more
europepmc   +1 more source

Expert consensus on the burden of respiratory syncytial virus disease and the utility of nirsevimab for disease prevention and protection of infants. [PDF]

World J Pediatr
Goh DYT, Goh A, Chen CK, Chan SM, Khoo PC, Thoon KC, Li J, Lee BW, Yung CF.   +8 more
europepmc   +1 more source

Is palivizumab effective as a prophylaxis of respiratory syncytial virus infections in cystic fibrosis patients? A meta-analysis

, 2013
Manuel Sánchez‐Solís, Silvia Gärtner, Vicente María Bosch-Giménez, Luis García‐Marcos   +3 more
openalex   +1 more source

A practical guidance on the prevention and treatment of childhood respiratory syncytial virus infection in Kurdistan. [PDF]

Front Pediatr
Haleem AA, Alsaqee A, Dizayi LA, Hanna SL, Rabaty AA, Pedawi S, Salih AF.   +6 more
europepmc   +1 more source

Monoclonal antibodies for preventing respiratory syncytial virus infection in children: a network meta-analysis. [PDF]

Cochrane Database Syst Rev
Garegnani L, Escobar Liquitay CM, Esteban I, Lenells M, Russo C, Bruschettini M, Franco JV, supported by Cochrane Sweden.   +7 more
europepmc   +1 more source

Prevention of respiratory syncytial virus disease by immunisation. [PDF]

Arch Dis Child Educ Pract Ed
Benzaken TR, Watson C, Drysdale SB.
europepmc   +1 more source